Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Other Non Operating Income (2016 - 2025)

Perspective Therapeutics' Other Non Operating Income history spans 9 years, with the latest figure at $2000.0 for Q2 2023.

  • For Q2 2023, Other Non Operating Income changed N/A year-over-year to $2000.0; the TTM value through Jun 2024 reached $2000.0, changed 0.0%, while the annual FY2023 figure was $2000.0, N/A changed from the prior year.
  • Other Non Operating Income for Q2 2023 was $2000.0 at Perspective Therapeutics, down from $7000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2000.0 in Q2 2023 and bottomed at $2000.0 in Q2 2023.